Bill to Reform FDA Accelerated Approval Process May Stymie Precision Oncology Progress, Experts Say
A bill that would impose a five-year expiration date on accelerated approvals may put pressure on precision oncology therapy research.
Stay updated with breaking news from Accelerating Access. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
A bill that would impose a five-year expiration date on accelerated approvals may put pressure on precision oncology therapy research.
Press release content from PR.com. The AP news staff was not involved in its creation.
Viz.ai, a San Francisco-based AI-powered disease detection and care coordination platform raises $1000M in Series D funding
To help ALS patients, former Obama staffers Brian Wallach and Sandra Abrevaya helped pass a new federal law expanding access to treatments.
Healthcare is an issue that can be addressed outside of partisan lines, particularly in the Senate. Let’s get some of these bills passed.